Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik; Vera Bril; Nan van Geloven; Hans-Peter Hartung; Richard A. Lewis; Gen Sobue; John-Philip Lawo; Michaela Praus; Orell Mielke; Billie L. Durn; David R. Cornblath; Ingemar S. J. Merkies; PATH Study Grp; Mika Saarela

doi:10.1016/S1474-4422(17)30378-2

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik
, Vera Bril
, Nan van Geloven
, Hans-Peter Hartung
, Richard A. Lewis
, Gen Sobue
, John-Philip Lawo
, Michaela Praus
, Orell Mielke
, Billie L. Durn
, David R. Cornblath
, Ingemar S. J. Merkies
, PATH Study Grp
, Mika Saarela

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Lancet Neurology
Volume	17
Issue number	1
Pages (from-to)	35-46
Number of pages	12
ISSN	1474-4422
DOIs	https://doi.org/10.1016/S1474-4422(17)30378-2
Publication status	Published - Jan 2018
MoE publication type	A1 Journal article-refereed

Fields of Science

QUALITY-OF-LIFE
PRIMARY ANTIBODY DEFICIENCIES
IGG SELF-INFUSIONS
MUSCLE STRENGTH
THERAPY
POLYRADICULONEUROPATHY
CIDP
HOME
ICE
SATISFACTION
3112 Neurosciences
3124 Neurology and psychiatry

Access to Document

10.1016/S1474-4422(17)30378-2

1-s2.0-S1474442217303782-mainFinal published version, 286 KB

Cite this

van Schaik, I. N., Bril, V., van Geloven, N., Hartung, H.-P., Lewis, R. A., Sobue, G., Lawo, J.-P., Praus, M., Mielke, O., Durn, B. L., Cornblath, D. R., Merkies, I. S. J., PATH Study Grp, & Saarela, M. (2018). Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurology, 17(1), 35-46. https://doi.org/10.1016/S1474-4422(17)30378-2

@article{b92d8eb82d20436c8bea4bb1c44584d3,

title = "Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial",

keywords = "QUALITY-OF-LIFE, PRIMARY ANTIBODY DEFICIENCIES, IGG SELF-INFUSIONS, MUSCLE STRENGTH, THERAPY, POLYRADICULONEUROPATHY, CIDP, HOME, ICE, SATISFACTION, 3112 Neurosciences, 3124 Neurology and psychiatry",

author = "\{van Schaik\}, \{Ivo N.\} and Vera Bril and \{van Geloven\}, Nan and Hans-Peter Hartung and Lewis, \{Richard A.\} and Gen Sobue and John-Philip Lawo and Michaela Praus and Orell Mielke and Durn, \{Billie L.\} and Cornblath, \{David R.\} and Merkies, \{Ingemar S. J.\} and \{PATH Study Grp\} and Mika Saarela",

note = "Mika Saarela ty{\"o}ryhm{\"a}n j{\"a}senen{\"a}.",

year = "2018",

month = jan,

doi = "10.1016/S1474-4422(17)30378-2",

language = "English",

volume = "17",

pages = "35--46",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd. ",

number = "1",

}

van Schaik, IN, Bril, V, van Geloven, N, Hartung, H-P, Lewis, RA, Sobue, G, Lawo, J-P, Praus, M, Mielke, O, Durn, BL, Cornblath, DR, Merkies, ISJ, PATH Study Grp & Saarela, M 2018, 'Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial', Lancet Neurology, vol. 17, no. 1, pp. 35-46. https://doi.org/10.1016/S1474-4422(17)30378-2

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. / van Schaik, Ivo N.; Bril, Vera; van Geloven, Nan et al.
In: Lancet Neurology, Vol. 17, No. 1, 01.2018, p. 35-46.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH)

T2 - a randomised, double-blind, placebo-controlled, phase 3 trial

AU - van Schaik, Ivo N.

AU - Bril, Vera

AU - van Geloven, Nan

AU - Hartung, Hans-Peter

AU - Lewis, Richard A.

AU - Sobue, Gen

AU - Lawo, John-Philip

AU - Praus, Michaela

AU - Mielke, Orell

AU - Durn, Billie L.

AU - Cornblath, David R.

AU - Merkies, Ingemar S. J.

AU - PATH Study Grp

AU - Saarela, Mika

N1 - Mika Saarela työryhmän jäsenenä.

PY - 2018/1

Y1 - 2018/1

KW - QUALITY-OF-LIFE

KW - PRIMARY ANTIBODY DEFICIENCIES

KW - IGG SELF-INFUSIONS

KW - MUSCLE STRENGTH

KW - THERAPY

KW - POLYRADICULONEUROPATHY

KW - CIDP

KW - HOME

KW - ICE

KW - SATISFACTION

KW - 3112 Neurosciences

KW - 3124 Neurology and psychiatry

U2 - 10.1016/S1474-4422(17)30378-2

DO - 10.1016/S1474-4422(17)30378-2

M3 - Article

SN - 1474-4422

VL - 17

SP - 35

EP - 46

JO - Lancet Neurology

JF - Lancet Neurology

IS - 1

ER -